| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 65 | 92 | 92 | 93 | 114 | 123 | 143 | 144 | 132 | 148 | 155 | 186 | 155 | 174 | 170 | 226 | 178 | 255 | 277 | 314 | 223 | 316 |
| Expenses | 52 | 69 | 70 | 70 | 91 | 95 | 111 | 118 | 108 | 119 | 122 | 146 | 120 | 179 | 140 | 182 | 147 | 198 | 206 | 224 | 156 | 211 |
| EBITDA | 14 | 23 | 22 | 23 | 23 | 28 | 31 | 26 | 24 | 29 | 34 | 41 | 35 | -5 | 30 | 44 | 31 | 57 | 70 | 91 | 67 | 105 |
| Operating Profit % | 20 % | 24 % | 24 % | 25 % | 20 % | 22 % | 21 % | 18 % | 18 % | 19 % | 20 % | 22 % | 22 % | -4 % | 16 % | 19 % | 17 % | 20 % | 25 % | 28 % | 25 % | 31 % |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 6 | 7 | 6 | 7 | 8 | 8 |
| Interest | 1 | 1 | 2 | 1 | 3 | 3 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 3 | 2 | 4 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 11 | 0 | 19 | 21 | 18 | 23 | 29 | 22 | 20 | 26 | 30 | 37 | 31 | -10 | 24 | 37 | 20 | 50 | 63 | 83 | 58 | 96 |
| Tax | 3 | -15 | 5 | 5 | 4 | 5 | 9 | 1 | 6 | 7 | 7 | 10 | 9 | 7 | 6 | 12 | 5 | 13 | 18 | 20 | 14 | 24 |
| Net Profit | 9 | 15 | 15 | 15 | 14 | 18 | 20 | 21 | 15 | 19 | 22 | 27 | 22 | -17 | 18 | 26 | 15 | 38 | 46 | 63 | 44 | 72 |
| EPS in ₹ | 8.49 | 4.83 | 4.59 | 4.89 | 4.36 | 5.11 | 5.69 | 6.22 | 4.08 | 5.50 | 6.28 | 7.47 | 4.57 | -4.67 | 4.83 | 6.85 | 3.67 | 9.38 | 11.35 | 7.80 | 5.41 | 8.82 |
Acutaas Chemicals
Acutaas Chemicals
1,768.60
-1.30
(-0.07%)
Key Fundamentals
Market Cap
14,479.34 Cr
EPS
19.91
PE Ratio
64.70
Dividend Yield
0.08 %
Industry
Healthcare 52 Week High
1,868.20
52 Week Low
918.78
PB Ratio
11.07
Debt to Equity
0.12
Sector
Pharmaceuticals Analyst Rating and Forecast
- By Refinitiv from6 analysts
Actual
Company News
View All News
Acutaas Chemicals Reports Strong Q2 FY26 Results with 24% Revenue Growth and Margin Expansion
Oct 24, 2025
Oct 24, 2025Acutaas Chemicals Limited reported revenue of INR 306.2 crores for Q2 FY26, representing 24.1% year-on-year growth. The company's EBITDA reached INR 95.3 crores with margins expanding to 31.1%, up 1,130 basis points year-on-year. PAT grew 91.3% to INR 71.9 crores with margins at 23.5%. The Advanced Pharmaceutical Intermediates segment drove growth with revenue of INR 262.6 crores, up 27.1% year-on-year, primarily from CDMO business expansion. Specialty Chemicals segment recorded INR 43.6 crores revenue with 7.3% growth. For H1 FY26, total revenue reached INR 513.4 crores, up 21.3% year-on-year. The company revised its EBITDA margin guidance to 28-30% for FY26 and maintains 25% revenue growth target. Capex of INR 141 crores in H1 focused on electrolyte additive project at Jaghadia site and pilot plant at Sachin site. The electrolyte additive plant is expected to be completed by Q4 FY26, while the Korea joint venture Indichem is expected to start contributing from H2 FY27. Working capital improved to 100 days from 128 days in Q1 FY26.
Acutass Chemicals Raises FY26 Revenue Growth Guidance to 25% with Improved EBITDA MarginsOct 20, 2025
Oct 20, 2025Acutass Chemicals anticipates a 25% revenue increase for FY26. The company has raised its EBITDA margin guidance for FY26 to 28-30% due to higher CDMO contributions. The specialty chemicals business is expected to grow by 10-15%. Working capital is projected to be between 95-105 days for the year.
AcutaaS Chemicals MD Targets 25% Revenue GrowthOct 17, 2025
Oct 17, 2025AcutaaS Chemicals' Managing Director expressed confidence in achieving approximately 25% revenue growth for the year.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,693.70 | #1 4,06,375.36 | 38.58 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 54.39 | |
6,669.50 | 1,77,054.27 | 79.27 | 9,712.00 | 18.67 | 2,191 | 35.10 | 74.24 | |
1,505.00 | 1,21,566.99 | 22.30 | 28,409.50 | 7.12 | 5,291 | 3.71 | 39.79 | |
3,581.00 | 1,21,197.31 | 60.08 | 11,539.40 | 6.99 | 1,911 | 19.91 | 46.89 | |
1,209.40 | 1,00,938.19 | #1 17.53 | 33,741.20 | 16.73 | 5,725 | -0.38 | 36.98 | |
942.30 | 94,817.43 | 20.00 | 23,511.00 | 18.55 | 4,615 | 34.60 | 30.29 | |
2,265.80 | 93,522.82 | 49.83 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 28.96 | |
1,970.50 | 90,003.48 | 24.00 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 50.08 | |
5,656.00 | 67,625.96 | 28.92 | 13,458.30 | 3.70 | 2,216 | 21.39 | 62.15 | |
1,124.30 | 65,299.53 | 19.54 | 32,345.60 | 9.43 | 3,484 | 3.81 | 59.80 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
41.21 %
Net Income Growth
229.36 %
Cash Flow Change
-5.46 %
ROE
70.41 %
ROCE
52.45 %
EBITDA Margin (Avg.)
29.64 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 213 | 232 | 413 | 659 | 767 | 1,096 | 1,549 |
| Fixed Assets | 79 | 85 | 186 | 205 | 259 | 427 | 570 |
| Current Assets | 124 | 121 | 216 | 430 | 457 | 496 | 792 |
| Capital Work in Progress | 2 | 12 | 0 | 3 | 30 | 125 | 130 |
| Investments | 2 | 2 | 1 | 2 | 2 | 0 | 0 |
| Other Assets | 131 | 133 | 225 | 450 | 477 | 543 | 848 |
| Total Liabilities | 213 | 232 | 413 | 659 | 767 | 1,096 | 1,549 |
| Current Liabilities | 106 | 95 | 166 | 129 | 163 | 285 | 202 |
| Non Current Liabilities | 25 | 26 | 80 | 7 | 10 | 128 | 27 |
| Total Equity | 82 | 112 | 167 | 522 | 594 | 683 | 1,320 |
| Reserve & Surplus | 72 | 101 | 135 | 486 | 558 | 637 | 1,269 |
| Share Capital | 11 | 11 | 32 | 36 | 36 | 37 | 41 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 3 | -2 | -0 | 3 | -1 | 8 | 20 | -1 | 156 |
| Investing Activities | -14 | -19 | -25 | -21 | -24 | -101 | -121 | -33 | -365 | -224 |
| Operating Activities | 10 | 29 | 9 | 15 | 27 | 28 | -12 | 66 | 125 | 118 |
| Financing Activities | 4 | -7 | 15 | 6 | 0 | 72 | 140 | -12 | 239 | 261 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | May 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 49.71 % | 41.05 % | 41.05 % | 41.05 % | 41.05 % | 39.41 % | 39.41 % | 39.41 % | 39.41 % | 38.93 % | 39.91 % | 39.91 % | 39.07 % | 35.98 % | 35.97 % | 35.96 % | 35.96 % | 32.66 % | 32.66 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 7.16 % | 0.00 % | 8.97 % | 10.01 % | 12.92 % | 13.87 % | 15.52 % | 16.48 % | 16.94 % | 16.85 % |
| DIIs | 0.00 % | 4.85 % | 2.63 % | 4.44 % | 3.01 % | 3.28 % | 3.72 % | 3.63 % | 5.23 % | 5.94 % | 5.55 % | 6.81 % | 8.81 % | 14.81 % | 19.93 % | 20.24 % | 18.31 % | 22.38 % | 22.59 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % |
| Public / Retail | 0.00 % | 42.98 % | 46.69 % | 44.74 % | 44.74 % | 38.35 % | 38.64 % | 38.96 % | 37.44 % | 36.13 % | 27.13 % | 30.01 % | 28.79 % | 26.06 % | 24.72 % | 23.56 % | 24.19 % | 23.27 % | 22.79 % |
| Others | 50.29 % | 11.11 % | 9.62 % | 9.77 % | 11.19 % | 18.96 % | 18.23 % | 18.00 % | 17.92 % | 11.84 % | 27.41 % | 14.30 % | 13.33 % | 10.22 % | 5.51 % | 4.71 % | 5.05 % | 4.74 % | 5.10 % |
| No of Share Holders | 0 | 28 | 1,38,182 | 97,547 | 93,922 | 87,044 | 85,563 | 78,786 | 70,352 | 72,897 | 83,344 | 95,784 | 92,721 | 90,329 | 93,394 | 95,756 | 1,14,060 | 1,19,890 | 1,08,664 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3 | 3 | 3 | 1.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.67 | 0.55 | 0.25 | 0.08 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Aug 2022 |  Dividend | ₹ 3.00 /share | 29 Jul 2022 | 469.45 | 519.43 |
| 18 Sept 2023 | Dividend | ₹ 3.00 /share | 18 Sept 2023 | 529.60 | 648.55 |
| 13 Sept 2024 | Dividend | ₹ 3.00 /share | 13 Sept 2024 | 596.08 | 730.05 |
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 692.10 | 768.08 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 736.58 | 806.00 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 988.83 | 953.60 |
| 16 Apr 2025 |  Change Of Name | NA | 16 Apr 2025 | 1,177.28 | 1,177.28 |
| 22 Feb 2025 |  Split | 5:10 | 25 Apr 2025 | 1,121.08 | 1,121.08 |
| 02 May 2025 | Quarterly Result Announcement | NA | 02 May 2025 | 1,100.75 | 1,130.50 |
| 10 May 2025 |  Extraordinary General Meeting | NA | 10 May 2025 | 1,177.28 | 1,160.05 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 1,187.60 | 1,167.70 |
| 18 Sept 2025 | Dividend | ₹ 1.50 /share | 18 Sept 2025 | 1,130.50 | 1,472.35 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 1,413.30 | 1,449.70 |
| 17 Oct 2025 | Quarterly Result Announcement | NA | 17 Oct 2025 | 1,421.55 | 1,552.25 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptOct 24, 2025
Oct 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Oct 18, 2025Recording Of Earnings Conference Call Held On October 17 2025Oct 17, 2025
Oct 17, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 17, 2025
Oct 17, 2025Announcement under Regulation 30 (LODR)-Investor PresentationOct 17, 2025
Oct 17, 2025Unaudited Standalone And Consolidated Financial Results For Second Quarter And Half Year Ended September 30 2025Oct 17, 2025
Oct 17, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On October 17 2025Oct 17, 2025
Oct 17, 2025Intimation Of Earnings Conference Call Scheduled On Friday October 17 2025 At 3.30 P.M. (IST)Oct 10, 2025
Oct 10, 2025Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 To Be Held On October 17 2025Oct 10, 2025
Oct 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Sep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-AllotmentSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Intimation Of Record Date For The Purpose Of Final Dividend For The FY 2024-25Sep 02, 2025
Sep 02, 2025Communication To Shareholders - Intimation On Deduction Of Tax On DividendSep 02, 2025
Sep 02, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 01, 2025
Sep 01, 2025Reg. 34 (1) Annual Report.Sep 01, 2025
Sep 01, 2025Reg. 34 (1) Annual Report.Sep 01, 2025
Sep 01, 2025Notice Of The 18Th AGM Of The Company Scheduled To Be Held On September 25 2025Sep 01, 2025
Sep 01, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 29, 2025
Aug 29, 2025Regulation 30 Update - Intimation Of Platinum Medal Accreditation/Rating By EcovadisAug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement Under Reg 30 Of SEBI (LODR) Regulations 2015Jul 30, 2025
Jul 30, 2025Recording Of Earnings Conference Call Held On July 30 2025Jul 30, 2025
Jul 30, 2025Statement Of Deviation & Variation For The Quarter Ended June 30 2025 - Preferential IssueJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025
Jul 30, 2025Unaudited Standalone And Consolidated Financial Results For First Quarter Ended June 30 2025Jul 30, 2025
Jul 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On July 30 2025Jul 30, 2025
Jul 30, 2025Intimation Of Change Of Name Of Wholly Owned Subsidiary Company From Ami Organics Electrolytes Private Limited To Acutaas Chemicals Electrolytes Private LimitedJul 28, 2025
Jul 28, 2025Intimation Of Earnings Conference Call Scheduled On Wednesday July 30 2025 At 4.30 P.M. (IST)Jul 25, 2025
Jul 25, 2025Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025 To Be Held On July 30 2025Jul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-AcquisitionJul 23, 2025
Jul 23, 2025Intimation Of Name Change Of Wholly Owned Subsidiary CompanyJul 17, 2025
Jul 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Jul 11, 2025Announcement under Regulation 30 (LODR)-Joint VentureJun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Intimation Under Reg 30 Of SEBI (LODR) Regulations 2015Jun 10, 2025
Jun 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 04, 2025
Jun 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
May 23, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 21, 2025
May 21, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change of Company NameMay 15, 2025
May 15, 2025Mutual Fund Holdings
SBI Large & Midcap Fund Direct Plan-Growth 
Kotak Multicap Fund Direct - Growth 
ITI Small Cap Fund Direct-Growth 
Tata ELSS Fund Direct-Growth 
Bank of India Small Cap Fund Direct-Growth 
Union Small Cap Fund Direct-Growth 
HDFC Pharma And Healthcare Fund Direct - Growth 
ICICI Prudential Manufacturing Fund Direct - Growth 
Motilal Oswal Focused Fund Direct-Growth 
TRUSTMF Flexi Cap Fund Direct - Growth 
WhiteOak Capital Mid Cap Fund Direct - Growth 
JM Small Cap Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 64.86
ATR(14)
Less Volatile 69.12
STOCH(9,6)
Neutral 58.58
STOCH RSI(14)
Neutral 30.07
MACD(12,26)
Bullish 7.81
ADX(14)
Strong Trend 41.69
UO(9)
Bearish 45.78
ROC(12)
Uptrend And Accelerating 7.47
WillR(14)
Neutral -28.89
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
